These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28793781)

  • 1. Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps.
    Murphy RA; Court R; Maartens G; Sunpath H
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1181-1184. PubMed ID: 28793781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.
    Rohr JK; Ive P; Horsburgh CR; Berhanu R; Shearer K; Maskew M; Long L; Sanne I; Bassett J; Ebrahim O; Fox MP
    PLoS One; 2016; 11(8):e0161469. PubMed ID: 27548695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
    Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
    Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy.
    Kerschberger B; Boulle AM; Kranzer K; Hilderbrand K; Schomaker M; Coetzee D; Goemaere E; Van Cutsem G
    J Int AIDS Soc; 2015; 18(1):20092. PubMed ID: 26403636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality after failure of antiretroviral therapy in sub-Saharan Africa.
    Keiser O; Tweya H; Braitstein P; Dabis F; MacPhail P; Boulle A; Nash D; Wood R; Lüthi R; Brinkhof MW; Schechter M; Egger M;
    Trop Med Int Health; 2010 Feb; 15(2):251-8. PubMed ID: 20003034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure.
    Shroufi A; Van Cutsem G; Cambiano V; Bansi-Matharu L; Duncan K; Murphy RA; Maman D; Phillips A
    AIDS; 2019 Aug; 33(10):1635-1644. PubMed ID: 31305331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.
    Boender TS; Kityo CM; Boerma RS; Hamers RL; Ondoa P; Wellington M; Siwale M; Nankya I; Kaudha E; Akanmu AS; Botes ME; Steegen K; Calis JC; Rinke de Wit TF; Sigaloff KC
    J Antimicrob Chemother; 2016 Oct; 71(10):2918-27. PubMed ID: 27342546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort.
    Hawkins C; Hertzmark E; Spiegelman D; Muya A; Ulenga N; Kim S; Khudyakov P; Christian B; Sando D; Aris E; Fawzi W
    J Antimicrob Chemother; 2017 Jul; 72(7):2060-2068. PubMed ID: 28387836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study.
    Nsanzimana S; Semakula M; Ndahindwa V; Remera E; Sebuhoro D; Uwizihiwe JP; Ford N; Tanner M; Kanters S; Mills EJ; Bucher HC
    BMC Infect Dis; 2019 Apr; 19(1):312. PubMed ID: 30953449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa.
    Guichet E; Aghokeng A; Serrano L; Bado G; Toure-Kane C; Eymard-Duvernay S; Villabona-Arenas CJ; Delaporte E; Ciaffi L; Peeters M
    AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1159-1162. PubMed ID: 27342228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of HIV-infected patients receiving second-line antiretroviral therapy in a resource-limited setting in Nigeria.
    Onyedum CC; Iroezindu MO; Chukwuka CJ; Anyaene CE; Obi FI; Young EE
    Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):608-14. PubMed ID: 23959002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Mortality With Delayed and Missed Switch to Second-Line Antiretroviral Therapy in South Africa.
    Bell Gorrod H; Court R; Schomaker M; Maartens G; Murphy RA
    J Acquir Immune Defic Syndr; 2020 May; 84(1):107-113. PubMed ID: 32032304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa.
    Fox MP; Cutsem GV; Giddy J; Maskew M; Keiser O; Prozesky H; Wood R; Hernán MA; Sterne JA; Egger M; Boulle A;
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):428-37. PubMed ID: 22433846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study.
    Estill J; Egger M; Blaser N; Vizcaya LS; Garone D; Wood R; Campbell J; Hallett TB; Keiser O;
    AIDS; 2013 Jun; 27(9):1483-92. PubMed ID: 23462219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A targeted approach for routine viral load monitoring in Malawian adults on antiretroviral therapy.
    Mungwira RG; Divala TH; Nyirenda OM; Kanjala M; Muwalo F; Mkandawire FA; Choko A; Taylor TE; Mallewa J; van Oosterhout JJ; Laufer MK; Laurens MB
    Trop Med Int Health; 2018 May; 23(5):526-532. PubMed ID: 29505108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.
    Petersen ML; Tran L; Geng EH; Reynolds SJ; Kambugu A; Wood R; Bangsberg DR; Yiannoutsos CT; Deeks SG; Martin JN
    AIDS; 2014 Sep; 28(14):2097-107. PubMed ID: 24977440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
    Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
    PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives.
    Harries AD; Zachariah R; van Oosterhout JJ; Reid SD; Hosseinipour MC; Arendt V; Chirwa Z; Jahn A; Schouten EJ; Kamoto K
    Lancet Infect Dis; 2010 Jan; 10(1):60-5. PubMed ID: 20129150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.